206 related articles for article (PubMed ID: 7543189)
1. Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.
Salonpää P; Krause K; Pelkonen O; Raunio H
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):446-52. PubMed ID: 7543189
[TBL] [Abstract][Full Text] [Related]
2. Regulation of CYP 2 A 5 induction by porphyrinogenic agents in mouse primary hepatocytes.
Salonpää P; Kottari S; Pelkonen O; Raunio H
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):8-13. PubMed ID: 9007836
[TBL] [Abstract][Full Text] [Related]
3. CYP2A5/CYP2A6 expression in mouse and human hepatocytes treated with various in vivo inducers.
Donato MT; Viitala P; Rodriguez-Antona C; Lindfors A; Castell JV; Raunio H; Gómez-Lechón MJ; Pelkonen O
Drug Metab Dispos; 2000 Nov; 28(11):1321-6. PubMed ID: 11038160
[TBL] [Abstract][Full Text] [Related]
4. Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa.
Su T; He W; Gu J; Lipinskas TW; Ding X
Drug Metab Dispos; 1998 Aug; 26(8):822-4. PubMed ID: 9698299
[TBL] [Abstract][Full Text] [Related]
5. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.
Abu-Bakar A; Moore MR; Lang MA
Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037
[TBL] [Abstract][Full Text] [Related]
6. Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2.
Abu-Bakar A; Satarug S; Marks GC; Lang MA; Moore MR
Toxicol Lett; 2004 Mar; 148(3):199-210. PubMed ID: 15041070
[TBL] [Abstract][Full Text] [Related]
7. Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression.
Hahnemann B; Salonpää P; Pasanen M; Mäenpää J; Honkakoski P; Juvonen R; Lang MA; Pelkonen O; Raunio H
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):289-94. PubMed ID: 1520280
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P4502A5 expression and inducibility by phenobarbital is modulated by cAMP in mouse primary hepatocytes.
Salonpää P; Pelkonen O; Kojo A; Pasanen M; Negishi M; Raunio H
Biochem Biophys Res Commun; 1994 Nov; 205(1):631-7. PubMed ID: 7528014
[TBL] [Abstract][Full Text] [Related]
9. Liver injury and expression of cytochromes P450: evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes.
Camus-Randon AM; Raffalli F; Béréziat JC; McGregor D; Konstandi M; Lang MA
Toxicol Appl Pharmacol; 1996 May; 138(1):140-8. PubMed ID: 8658503
[TBL] [Abstract][Full Text] [Related]
10. Acute sodium arsenite treatment induces Cyp2a5 but not Cyp1a1 in the C57Bl/6 mouse in a tissue (kidney) selective manner.
Seubert JM; Webb CD; Bend JR
J Biochem Mol Toxicol; 2002; 16(2):96-106. PubMed ID: 11979426
[TBL] [Abstract][Full Text] [Related]
11. Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.
Salonpää P; Iscan M; Pasanen M; Arvela P; Pelkonen O; Raunio H
Biochem Pharmacol; 1992 Oct; 44(7):1269-74. PubMed ID: 1417950
[TBL] [Abstract][Full Text] [Related]
12. cAMP mediated upregulation of CYP2A5 in mouse hepatocytes.
Viitala P; Posti K; Lindfors A; Pelkonen O; Raunio H
Biochem Biophys Res Commun; 2001 Jan; 280(3):761-7. PubMed ID: 11162586
[TBL] [Abstract][Full Text] [Related]
13. Pyrazole-inducible proteins in DBA/2 mouse liver bind with high affinity to the 3'-untranslated regions of the mRNAs of coumarin hydroxylase (CYP2A5) and c-jun.
Thulke-Gross M; Hergenhahn M; Tilloy-Ellul A; Lang M; Bartsch H
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):473-81. PubMed ID: 9531487
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway.
Arpiainen S; Raffalli-Mathieu F; Lang MA; Pelkonen O; Hakkola J
Mol Pharmacol; 2005 Apr; 67(4):1325-33. PubMed ID: 15657367
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions.
Wastl UM; Rossmanith W; Lang MA; Camus-Randon AM; Grasl-Kraupp B; Bursch W; Schulte-Hermann R
Mol Carcinog; 1998 Aug; 22(4):229-34. PubMed ID: 9726815
[TBL] [Abstract][Full Text] [Related]
16. The role of stress in the regulation of drug metabolizing enzymes in mice.
Konstandi M; Marselos M; Radon-Camus AM; Johnson E; Lang MA
Eur J Drug Metab Pharmacokinet; 1998; 23(4):483-90. PubMed ID: 10323331
[TBL] [Abstract][Full Text] [Related]
17. Heme and heme biosynthesis intermediates induce heme oxygenase-1 and cytochrome P450 2A5, enzymes with putative sequential roles in heme and bilirubin metabolism: different requirement for transcription factor nuclear factor erythroid- derived 2-like 2.
Lämsä V; Levonen AL; Sormunen R; Yamamoto M; Hakkola J
Toxicol Sci; 2012 Nov; 130(1):132-44. PubMed ID: 22859313
[TBL] [Abstract][Full Text] [Related]
18. Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.
Gilmore WJ; Hartmann G; Piquette-Miller M; Marriott J; Kirby GM
Toxicology; 2003 Mar; 184(2-3):211-26. PubMed ID: 12499123
[TBL] [Abstract][Full Text] [Related]
19. Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes.
Kojo A; Viitala P; Pasanen M; Pelkonen O; Raunio H; Juvonen R
Arch Toxicol; 1998 May; 72(6):336-41. PubMed ID: 9657280
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between CYP2A5 induction and apoptosis in mouse primary hepatocytes.
Tetri S; Ruhanen M; Viitala P; Pelkonen O; Pasanen M; Raunio H
Biochem Pharmacol; 2002 Feb; 63(3):429-35. PubMed ID: 11853694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
